echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Production Process of Daunorubicin hydrochloride

    The Production Process of Daunorubicin hydrochloride

    • Last Update: 2023-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Daunorubicin is an anthracycline chemotherapy drug that is widely used to treat various types of cancer, including leukemia, lymphoma, and breast cancer.
    It is produced through a complex chemical synthesis process that involves several steps, starting with the extraction of the active ingredient from the soil bacterium Streptomyces peucetius.


    The production process of Daunorubicin hydrochloride can be broken down into several stages, including:


    Stage 1: Extraction and fermentation
    The active ingredient of Daunorubicin is produced by a microorganism called Streptomyces peucetius, which is found in soil.
    The first step in the production process is to extract the active ingredient from the microorganism.
    This is usually done by growing the microorganism in a nutrient-rich medium and then isolating the active ingredient from the culture broth using techniques such as centrifugation and filtration.


    Stage 2: Chemical synthesis
    Once the active ingredient has been extracted, the next step is to perform chemical synthesis to produce the final drug.
    This involves a series of chemical reactions that convert the extracted active ingredient into Daunorubicin hydrochloride.
    The synthesis process requires the use of specialized equipment and strict quality control measures to ensure that the final product is of the highest quality.


    Stage 3: Purification
    After the Daunorubicin hydrochloride has been synthesized, it must be purified to remove any impurities that may have been introduced during the synthesis process.
    This is typically done using a combination of chromatographic techniques such as column chromatography and high-performance liquid chromatography (HPLC).


    Stage 4: Formulation
    The final step in the production process is to formulate the drug into a dosage form that can be administered to patients.
    This involves mixing the purified Daunorubicin hydrochloride with excipients, such as lactose or mannitol, to create a stable and effective dosage form.
    The formulation process also includes filling and packaging the drug into the appropriate container.


    Quality control


    Throughout the production process, it is essential to perform quality control tests to ensure that the final product meets the required standards for purity, potency, and stability.
    These tests include:


    • Physical tests, such as determining the drug's melting point, solubility, and stability
    • Chemical tests, such as identifying the presence of impurities using techniques such as HPLC and TLC
    • Microbiological tests, such as testing for the presence of bacteria and mold

    Production scale


    The production scale of Daunorubicin hydrochloride can vary depending on the manufacturer and the demand for the drug.
    In general, the production process is scaled up from small laboratory-scale reactions to larger commercial-scale reactions.
    The production scale is typically carried out in large reactors and the purification steps are also scaled up accordingly.


    Conclusion


    The production of Daunorubicin hydrochloride is a complex process that involves several steps, starting with the extraction of the active ingredient from a microorganism and ending with the formulation of the final drug product.
    To ensure the quality of the final product, strict quality control measures are implemented throughout the production process.
    The production scale can vary depending on the manufacturer and the demand for the drug.
    Understanding the production process of Daunorubicin hydrochloride is essential for ensuring the safe and effective use of this important chemotherapy drug.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.